Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival.

Laila Schneidewind,Desirée Louise Dräger,Vanessa Roßberg,Julia Nolting,Oliver W Hakenberg

Urologia internationalis（2023）

引用 0|浏览2

暂无评分

摘要

Physical and emotional needs have a strong impact on HRQoL and should be dealt with during treatment. If symptom burden is high, survival decreases. This needs further evaluation.

查看译文

关键词

Functional assessment of cancer therapy,Health-related quality of life,Immunotherapy,Metastatic urothelial carcinoma,Pembrolizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要